FDA approves new combination drug from Novartis to reduce heart failure deaths

Government regulators have approved a new pill from Novartis to treat heart failure, a deadly chronic disease that affects millions of U.S. patients. The Food and Drug Administration approved the combination drug, Entresto, based on studies showing it reduced rates of heart-related death and hospitalization compared with older drugs.